Breaking News

OSF Ventures’ new leader will focus investments on alternative care modalities, workforce retention 

Not rendering correctly? View this email as a web page here.

How UCSF's accelerator is helping health tech reach more low-income patients

By Katie Adams Wednesday, July 6, 2022 7:17 PM

The low-income patient populations who bear disproportionate disease burdens are the same populations who are most likely to face barriers in health technology use, according to Courtney Lyles co-founder of S.O.L.V.E. Health Tech, UCSF's health equity accelerator. The program she co-founded seeks to address this problem by conducting research with digital health startups about how their products can better serve low-income patients.

Read more »

Remote Therapeutic Monitoring (RTM): A gateway to hybrid musculoskeletal care

By Ryan Eder and Thomas Santo Wednesday, July 6, 2022 7:07 PM

A new set of 5 CMS codes introduced for 2022, RTM allows physical therapists and other qualified healthcare professionals to bill for monitoring and managing a patient's MSK care plan remotely

Read more »

How Pfizer won the pandemic, reaping outsize profit and influence

By Arthur Allen, Kaiser Health News Wednesday, July 6, 2022 6:54 PM

Because the virus keeps mutating and will be around for a long time, the market for Pfizer's products won't go away. In wealthier countries, the public is likely to keep coming back for more, like diners at an all-you-can-eat restaurant, sated but never entirely satisfied.

Read more »

With new gene therapy data in hand, Sarepta talks with FDA about approval pathways

By Frank Vinluan Wednesday, July 6, 2022 6:17 PM

Sarepta Therapeutics has more clinical data showing the safety and efficacy of its experimental gene therapy for Duchenne muscular dystrophy. A pivotal Phase 3 test is already underway and could post data next year but the company is also talking with regulators about the possibility of a submission under the accelerated approval pathway.

Read more »

   

No comments